News Contact Us Careers Get E-Mail alerts Search

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

News

See below for our most recent and archived news events.

Click below for current and archived news related to the company.

ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions

Nov 15, 2017 8:08am EST

ADMA Biologics Announces Closing of $42M Follow-On Offering

Nov 13, 2017 12:30pm EST

ADMA Biologics Announces Pricing of Follow-On Offering

Nov 09, 2017 8:58am EST

ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

Nov 03, 2017 5:02pm EDT

Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing

Oct 11, 2017 7:11am EDT

ADMA Biologics to Present at Upcoming Investor Conferences

Aug 23, 2017 7:38am EDT

ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results

Aug 11, 2017 4:15pm EDT

ADMA Biologics Strengthens Patent Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Methods

Jul 31, 2017 4:15pm EDT

ADMA Biologics Provides Corporate Timeline and Activities Update to Stockholders

Jun 27, 2017 7:08am EDT

ADMA Biologics Completes Acquisition of Biotest’s Therapy Business Unit Assets

Jun 06, 2017 3:33pm EDT

1...
2
3
4
5
6
7
8
9
10
11
...16